Bluejay Therapeutics Alternatives & Competitors
12 companies similar to Bluejay Therapeutics — Developing innovative cures for infectious diseases with the first target indica...
Companies similar to Bluejay Therapeutics
InflaRx
Controlling Inflammation - developing drugs to treat life threatening and chronic inflamma...
Jena, Germany
Evommune
Developing innovative therapies that target key drivers of chronic inflammatory diseases.
Palo Alto, United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Rival Readout
Competing with Bluejay Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Alltrna
The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeu...
Cambridge, United States
Cajal Therapeutics
Cajal Therapeutics is a Seattle biotechnology company dedicated to developing innovative m...
Seattle, United States
FimmCyte
First disease modifying treatment for Endometriosis.
Basel, Switzerland
HepaRegeniX GmbH
Unlocking liver regeneration - delivering recovery
Tubingen, Germany
Yaqrit
The Liver Disease Company
London, United Kingdom
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
CytoDyn
CytoDyn’s purpose is to help enhance the lives of patients with life-threatening diseases.
Vancouver, United States
Cabaletta Bio
Engineered T cell therapies designed for the treatment of patients with autoimmune disease...
Philadelphia, United Stat...
About Bluejay Therapeutics
Bluejay Therapeutics, founded in 2020 and headquartered in the United States, is making significant strides in the Biotechnology, Health Care, and Pharmaceutical industries. The company is dedicated to developing innovative cures for infectious diseases, with a promising initial focus on the chronic HDV infection. Unde...
Development of therapeutics for liver diseases, Acquisition and integration of biotech companies, Research and development in chronic hepatitis delta virus treatment
Patients with liver diseases, Healthcare providers, Biotechnology investors, Medical professionals specializing in rare diseases
Biopharmaceutical, Infectious Diseases, Chronic HDV Infection, Hepatitis B, Functional Cure, Monoclonal Antibodies, IgG1 Anti-HBs, HBsAg Inhibitors, Small Molecule Inhibitors, Adaptive Immunity Restoration, Medical Innovation, Healthcare Solutions, Immunotherapy, Therapeutic Development, Biotechnology Startup
B2B
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Bluejay Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Bluejay Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 10 Nov 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
